The Three E’s of Measurable R&D

BY Roger Pellegrini
November 7, 2018

Given the rising costs, protracted timelines, and increasing complexity of large molecule R&D, scientists, group heads, and executives all need to take a data-driven approach to optimizing their own processes and decision-making. Especially for companies working in emerging drug modalities, knowing exactly what to measure – and what actions to take in light of certain data – can give you a competitive advantage.

From answering questions like, “For a particular process, what’s our average yield?” to answering, “Over time, where within our R&D organization have we made funding changes?”, taking a data-driven approach to R&D can create value at all levels of an organization.

In this series, we explore a framework for scientists, group heads, and executives to measure the success of their programs.

For Scientists

For Group Heads

For Executives

Learn More About Benchling

 

Published by Roger Pellegrini
VIEW ALL POSTS BY Roger Pellegrini

Leave a Reply

%d bloggers like this: